Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-risk Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT04495010
What this trial is testing

Neoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Nivolumab or Neoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Observation Compared With Adjuvant Nivolumab in Treatment-Naive High-risk Melanoma Participants

Who this might be right for
Melanoma
Bristol-Myers Squibb
Testing effectiveness (Phase 2)Active Not RecruitingNCT04486378
What this trial is testing

A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer

Who this might be right for
Colorectal Cancer Stage IIColorectal Cancer Stage III
BioNTech SE 327
Testing effectiveness (Phase 2)Study completedNCT00065143
What this trial is testing

Clofarabine Plus Cytarabine in Patients With Previously Untreated Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome

Who this might be right for
Leukemia, MyeloidMyelodysplastic Syndromes
M.D. Anderson Cancer Center 60
Testing effectiveness (Phase 2)Looking for participantsNCT07562490
What this trial is testing

Controlled Trial of Plasma ctDNA Methylation-Guided Adjuvant Chemotherapy Decision-Making in High-Risk Stage III (T4N+ or T1-3N2) Colorectal Cancer

Who this might be right for
ctDNAChemotherapyColorectal Cancer
Fudan University 100
Large-scale testing (Phase 3)Looking for participantsNCT06071897
What this trial is testing

Induction Chemoimmunotherapy for Patients With High-risk Neuroblastoma

Who this might be right for
NeuroblastomaGanglioneuroblastoma
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 15
Large-scale testing (Phase 3)Looking for participantsNCT05946213
What this trial is testing

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage III Prostate Cancer AJCC v8Stage IVA Prostate Cancer AJCC v8
NRG Oncology 1,209
Testing effectiveness (Phase 2)Looking for participantsNCT06758882
What this trial is testing

Surgical Treatment With or Without Apalutamide in Subjects With High Risk Prostate Cancer Who Are Candidates for Radical Prostatectomy and Staged as Oligometastatic With PSMA-PET

Who this might be right for
High Risk Prostate Cancer
Marco Oderda 94
Not applicableEnded earlyNCT03922776
What this trial is testing

Phenotypic Characterization Tumor-infiltrating Lymphocytes at Diagnosis and After Chemotherapy in Ovarian Cancer

Who this might be right for
Ovarian Cancer Stage IIICFallopian Tube Cancer Stage IIICFallopian Tube Cancer Stage IV+1 more
Centre Oscar Lambret 36
Testing effectiveness (Phase 2)Ended earlyNCT02806258
What this trial is testing

Comparing Sequential Neoadjuvant Treatment Including Chemotherapy and Accelerated Radiation Focused to the Tumor Bed vs Neoadjuvant Chemotherapy Alone

Who this might be right for
Radiation Therapy, Breast Cancer, Sequential Partial Breast IrradiationIntermediate and High-risk Luminal and Triple Negative Breast Cancer
University Hospital, Grenoble 362
Early research (Phase 1)Study completedNCT02485535
What this trial is testing

Selinexor in Treating Patients With Intermediate- and High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome After Transplant

Who this might be right for
Acute Myeloid Leukemiade Novo Myelodysplastic SyndromeMyelodysplastic Syndrome+2 more
University of Chicago 12
Early research (Phase 1)Study completedNCT00987376
What this trial is testing

Novel PET/CT Agents and MRS/MRI in Prostate CA and High Risk Prostate Cancer: An Inter-SPORE Collaboration

Who this might be right for
Prostate Cancer
Mayo Clinic 8
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07562568
What this trial is testing

SHR2554/AZA + Overlapped TBF for High-risk/Relapsed Leukemia/MDS

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMDS+4 more
The First Affiliated Hospital of Soochow University 160
Not applicableStudy completedNCT01060982
What this trial is testing

Observation of Histological Changes in Parathyroid Adenomas Following High Intensity Focused Ultrasound (HIFU) Treatment Procedure

Who this might be right for
Primary Parathyroid Adenomas
Theraclion 5
Testing effectiveness (Phase 2)Looking for participantsNCT02559778
What this trial is testing

Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

Who this might be right for
Neuroblastoma
Giselle Sholler 500
Early research (Phase 1)Looking for participantsNCT07501117
What this trial is testing

Neoadjuvant Immunotherapy for Patients With High-risk Eye Melanoma

Who this might be right for
Uveal Melanoma
Inge Marie Svane 15
Testing effectiveness (Phase 2)Study completedNCT01176552
What this trial is testing

Granulocyte-macrophage Colony-stimulating Factor, Interferon and Interleukin-2 as Adjuvant Treatment for Renal Cancer

Who this might be right for
Renal Cell Carcinoma
Kidney Cancer Research Bureau 35
Early research (Phase 1)Looking for participantsNCT07249840
What this trial is testing

Ropeginterferon for High Risk JAK2 Clonal Hematopoiesis

Who this might be right for
JAK2 Mutation
Brigham and Women's Hospital 12
Testing effectiveness (Phase 2)Study completedNCT00475150
What this trial is testing

Cediranib Maleate in Treating Patients With Relapsed, Refractory, or Untreated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+8 more
National Cancer Institute (NCI) 39
Not applicableStudy completedNCT03343249
What this trial is testing

Adjunctive Smart Phone Based Smoking Cessation Treatment

Who this might be right for
High-Risk Cancer
University of Texas Southwestern Medical Center 75
Not applicableStudy completedNCT01097278
What this trial is testing

S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer

Who this might be right for
brca1 Mutation Carrierbrca2 Mutation CarrierBreast Cancer
SWOG Cancer Research Network 208
Next Page